Mixed neuroendocrine-non-neuroendocrine neoplasm associated with autoimmune gastritis.

adenocarcinoma autoimmune gastritis endoscopic submucosal dissection mixed neuroendocrine‐non‐neuroendocrine neoplasms

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 31 01 2022
revised: 22 02 2022
accepted: 07 03 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

A 60-year-old woman presented with a protruding tumor at the anterior wall of the middle gastric body, and she was positive for anti-parietal cells antibodies with elevated serum gastrin level. Final diagnosis was a mixed neuroendocrine-non-neuroendocrine neoplasm consisting of adenocarcinoma (tub1) and neuroendocrine tumor G2 with autoimmune gastritis.

Identifiants

pubmed: 35356166
doi: 10.1002/ccr3.5640
pii: CCR35640
pmc: PMC8940597
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e05640

Informations de copyright

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interest.

Références

Virchows Arch. 2021 Jul;479(1):169-178
pubmed: 33515301
Pathologica. 2021 Feb;113(1):5-11
pubmed: 33686305
BMC Cancer. 2018 Oct 22;18(1):1021
pubmed: 30348122
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Med Sci (Basel). 2021 Jun 25;9(3):
pubmed: 34201925
Exp Ther Med. 2021 Oct;22(4):1179
pubmed: 34475969
United European Gastroenterol J. 2020 Mar;8(2):175-184
pubmed: 32213076
Neuroendocrinology. 2014;100(4):310-6
pubmed: 25342539
Gastric Cancer. 2014 Apr;17(2):263-72
pubmed: 23828549
Gastroenterology. 1993 Apr;104(4):994-1006
pubmed: 7681798
Digestion. 2022;103(1):45-53
pubmed: 34628409
Front Oncol. 2021 Aug 04;11:709097
pubmed: 34422662
Nat Rev Endocrinol. 2020 Oct;16(10):590-607
pubmed: 32839579
Int J Mol Sci. 2018 Jan 26;19(2):
pubmed: 29373557
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Mod Pathol. 2020 Dec;33(12):2602-2613
pubmed: 32461621
J Clin Endocrinol Metab. 2008 Feb;93(2):363-71
pubmed: 18029461
Br J Cancer. 2016 Dec 6;115(12):1540-1547
pubmed: 27875519
Eur J Surg Oncol. 2018 Dec;44(12):1955-1962
pubmed: 30201419

Auteurs

Naoko Mori (N)

Division of Gastroenterology Omi Medica Center Shiga Japan.

Masanori Hongo (M)

Division of Gastroenterology Omi Medica Center Shiga Japan.

Shizuki Takemura (S)

Division of Pathology Omi Medica Center Shiga Japan.

Yoshihiko Sugitani (Y)

Division of Gastroenterology Omi Medica Center Shiga Japan.

Fumiyasu Nakamura (F)

Division of Gastroenterology Omi Medica Center Shiga Japan.

Masaji Tani (M)

Department of Surgery Shiga University of Medical Science Shiga Japan.

Atsushi Nishida (A)

Department of Medicine Shiga University of Medical Science Shiga Japan.

Osamu Inatomi (O)

Department of Medicine Shiga University of Medical Science Shiga Japan.

Akira Andoh (A)

Department of Medicine Shiga University of Medical Science Shiga Japan.

Hiromitsu Ban (H)

Division of Gastroenterology Omi Medica Center Shiga Japan.

Classifications MeSH